Cargando…
124. Impact of Levofloxacin MIC on Outcomes with Levofloxacin Step-down Therapy in Enterobacteriaceae Bloodstream Infections
BACKGROUND: The Clinical and Laboratory Standards Institute reduced the levofloxacin minimum inhibitory concentration (MIC) breakpoint from ≤2 to ≤0.5 mg/L for Enterobacteriaceae in 2019 guidelines. The reduction is based on Monte Carlo simulations for a levofloxacin dose of 750 mg daily. The aim of...
Autores principales: | White, Melissa, Lenzi, Kerry, Dutcher, Lauren S, Saw, Stephen, Morgan, Steven C, Binkley, Shawn, Athans, Vasilios, Cimino, Christo L, Degnan, Kathleen, Hamilton, Keith W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809892/ http://dx.doi.org/10.1093/ofid/ofz360.199 |
Ejemplares similares
-
54. Effectiveness of a Venous Catheter Stewardship Intervention Targeting Parenteral Antimicrobial Therapy at Hospital Discharge
por: Athans, Vasilios, et al.
Publicado: (2020) -
82. Assessment of Clinical Outcomes and Antibiotic Prescribing Patterns Following Implementation of the GenMark ePlex(®) Blood Culture Identification Panel for Gram-positive Bloodstream Infections
por: Wein, Megan, et al.
Publicado: (2021) -
168. Syndrome-Based Analysis of Oral Antimicrobial Stewardship Opportunities at Hospital Discharge
por: Cunningham, Jessica, et al.
Publicado: (2021) -
1759. Risk Factors for OPAT-Related Adverse Drug Events: A Case-Control Study
por: Burke, Elysia, et al.
Publicado: (2022) -
905. Impact of a Real-Time Electronic Alert on Antibiotic Treatment Duration for Pneumonia in Hospitalized Patients
por: Degnan, Kathleen, et al.
Publicado: (2022)